Answers are grounded in this paper and cite their sources.
A scoping review highlights AI's role in improving immune checkpoint inhibitor safety, suggesting further validation is needed.
AI shows potential to enhance ICI safety by enabling earlier detection of irAEs, personalized risk prediction, and scalable clinical support tools. To support clinical translation, future research must prioritize external and prospective validation, standardized outcome reporting, and impact evaluation (eg, effects on clinical outcomes and workflows) within robust governance frameworks.
No takes yet. Share an insight, caveat, or question.
Yiu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: